OpenBilldrug price receipt

NADAC week of 2026-10-14

ACETAZOLAMIDE 250 MG TABLET

For 30 tablets

Pharmacies pay

$4.02 filed

30 × $0.13397 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$18.24 filed

30 × $0.6079 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

4.5× estimated

Medicare paid 4.5× what pharmacies pay.

Part D averages every strength and form sold under “Acetazolamide” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$9.62 estimated

$4.02 + $0.60 (15%) + $5.00 fee per fill = $9.62

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ACETAZOLAMIDE 250 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as acetazolamide.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 12 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. and AvPAK.

FDA’s Established Pharmacologic Class for it is Carbonic Anhydrase Inhibitor.

The NADAC file of 2026-10-14 prices it under 13 NDCs (National Drug Codes); the FDA directory lists 12 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $4.02 for 30 tablets (30 × $0.13397 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 12 labelers

LabelerNDCsPharmacies pay per unit
ANI Pharmaceuticals, Inc.1$0.13397 per EA filed
Advagen Pharma Ltd1$0.13397 per EA filed
Aurobindo Pharma Limited1$0.13397 per EA filed
AvPAK1$0.13397 per EA filed
Chartwell RX, LLC1$0.13397 per EA filed
Eywa Pharma Inc1$0.13397 per EA filed
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1$0.13397 per EA filed
Lifestar Pharma LLC1$0.13397 per EA filed
Major Pharmaceuticals1$0.13397 per EA filed
Strides Pharma Science Limited1$0.13397 per EA filed
TRUPHARMA, LLC1$0.13397 per EA filed
Viona Pharmaceuticals Inc1$0.13397 per EA filed
Not listed as a package in the FDA directory1$0.13397 per EA filed
All 13 NDCs, with labeler and price
  • 00904-6663-61 · Major Pharmaceuticals · $0.13397 per EA · eff. 2026-09-23 filed
  • 23155-0288-01 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.13397 per EA · eff. 2026-09-23 filed
  • 50268-0054-11 · not listed as a package in the FDA directory · $0.13397 per EA · eff. 2026-09-23 filed
  • 50268-0054-15 · AvPAK · $0.13397 per EA · eff. 2026-09-23 filed
  • 52817-0201-10 · TRUPHARMA, LLC · $0.13397 per EA · eff. 2026-09-23 filed
  • 59651-0906-01 · Aurobindo Pharma Limited · $0.13397 per EA · eff. 2026-09-23 filed
  • 62135-0608-12 · Chartwell RX, LLC · $0.13397 per EA · eff. 2026-09-23 filed
  • 64380-0834-06 · Strides Pharma Science Limited · $0.13397 per EA · eff. 2026-09-23 filed
  • 70756-0721-11 · Lifestar Pharma LLC · $0.13397 per EA · eff. 2026-09-23 filed
  • 70954-0034-30 · ANI Pharmaceuticals, Inc. · $0.13397 per EA · eff. 2026-09-23 filed
  • 71930-0009-12 · Eywa Pharma Inc · $0.13397 per EA · eff. 2026-09-23 filed
  • 72578-0150-01 · Viona Pharmaceuticals Inc · $0.13397 per EA · eff. 2026-09-23 filed
  • 72888-0048-01 · Advagen Pharma Ltd · $0.13397 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name acetazolamide with ACETAZOLAMIDE 250 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
ACETAZOLAMIDE 125 MG TABLET
generic · tablet
$0.09649 per EA filed
eff. 2026-09-23
$0.6079 per EA filed
Part D 2024 average
ACETAZOLAMIDE 250 MG TABLET this page
generic · tablet
$0.13397 per EA filed
eff. 2026-09-23
$0.6079 per EA filed
Part D 2024 average
ACETAZOLAMIDE ER 500 MG CAP
generic · capsule, extended release / capsule
$0.28822 per EA filed
eff. 2026-09-23
$0.77281 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 13 NDCs’ NADAC prices is $0.13397 per EA filed.

Of the 4 other products in FDA’s Carbonic Anhydrase Inhibitor class priced per EA, 3 have a higher middle NADAC price and 1 a lower one. The one in the middle is ACETAZOLAMIDE ER 500 MG CAP, at $0.28822 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $18.24 for 30 tablets, at an average of $0.6079 per EA in 2024 (2024-01-01 to 2024-12-31) for “Acetazolamide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 246,007 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ACETAZOLAMIDE 250 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Acetazolamide / Acetazolamide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.